137 related articles for article (PubMed ID: 23550632)
1. Training health workers for magnesium sulfate use reduces case fatality from eclampsia: results from a multicenter trial.
Okonofua FE; Ogu RN; Fabamwo AO; Ujah IO; Chama CM; Archibong EI; Onah HE; Galadanci HS; Akuse JT
Acta Obstet Gynecol Scand; 2013 Jun; 92(6):716-20. PubMed ID: 23550632
[TBL] [Abstract][Full Text] [Related]
2. Maternal and fetal outcomes after introduction of magnesium sulphate for treatment of preeclampsia and eclampsia in selected secondary facilities: a low-cost intervention.
Tukur J; Ahonsi B; Ishaku SM; Araoyinbo I; Okereke E; Babatunde AO
Matern Child Health J; 2013 Sep; 17(7):1191-8. PubMed ID: 22956402
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome in eclamptics at the University of Abuja Teaching Hospital, Gwagwalada, Abuja: a 3 year review.
Agida ET; Adeka BI; Jibril KA
Niger J Clin Pract; 2010 Dec; 13(4):394-8. PubMed ID: 21220852
[TBL] [Abstract][Full Text] [Related]
4. Magnesium sulphate: a life saving drug.
Thapa K; Jha R
JNMA J Nepal Med Assoc; 2008; 47(171):104-8. PubMed ID: 19079372
[TBL] [Abstract][Full Text] [Related]
5. Benefits of using magnesium sulphate (MgSO₄) for eclampsia management and maternal mortality reduction: lessons from Kano State in Northern Nigeria.
Okereke E; Ahonsi B; Tukur J; Ishaku SM; Oginni AB
BMC Res Notes; 2012 Aug; 5():421. PubMed ID: 22873658
[TBL] [Abstract][Full Text] [Related]
6. Management of eclampsia at AKTH: before and after magnesium sulphate.
Tukur J; Muhammad Z
Niger J Med; 2010; 19(1):104-7. PubMed ID: 20232764
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome in women with eclampsia at a tertiary centre in northern Nigeria.
Adamu AN; Ekele BA; Ahmed Y; Mohammed BA; Isezuo SA; Abdullahpi AA
Afr J Med Med Sci; 2012 Jun; 41(2):211-9. PubMed ID: 23185921
[TBL] [Abstract][Full Text] [Related]
8. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia.
Tukur J
Ann Afr Med; 2009; 8(2):76-80. PubMed ID: 19805935
[TBL] [Abstract][Full Text] [Related]
9. Introduction of an innovation for the reduction of maternal mortality in Kano State, northern Nigeria: a case study of magnesium sulphate.
Tukur J; Ogedengbe C; Nwanchukwu E; Araoyinbo IA; Yakasai IA; Adaji SE; Ajala B
Trop Doct; 2011 Oct; 41(4):197-200. PubMed ID: 21831930
[TBL] [Abstract][Full Text] [Related]
10. [Magnesium sulfate in the prophylaxis of eclampsia: a retrospective study].
Bourret B; Compère V; Torre S; Azhougagh K; Provost D; Rachet B; Gillet R; Rieu M; Marpeau L; Dureuil B
Ann Fr Anesth Reanim; 2012 Dec; 31(12):933-6. PubMed ID: 23117038
[TBL] [Abstract][Full Text] [Related]
11. Ecalmpsia: maternal and fetal outcome.
Jido TA
Afr Health Sci; 2012 Jun; 12(2):148-52. PubMed ID: 23056020
[TBL] [Abstract][Full Text] [Related]
12. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of Magnesium sulfate.
Ugwu EO; Dim CC; Okonkwo CD; Nwankwo TO
Niger J Clin Pract; 2011; 14(4):418-21. PubMed ID: 22248941
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcome of patients with eclampsia at a tertiary hospital in Egypt.
Mahran A; Fares H; Elkhateeb R; Ibrahim M; Bahaa H; Sanad A; Gamal A; Zeeneldin M; Khalifa E; Abdelghany A
BMC Pregnancy Childbirth; 2017 Dec; 17(1):435. PubMed ID: 29272998
[TBL] [Abstract][Full Text] [Related]
14. Use of magnesium sulfate in pre-eclampsia and eclampsia in teaching hospitals in Addis Ababa: a practice audit.
Getaneh W; Kumbi S
Ethiop Med J; 2010 Apr; 48(2):157-64. PubMed ID: 20608019
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the use of magnesium sulphate in pre-eclampsia/eclampsia management in health facilities in Northern Nigeria: a mixed methods study.
Oguntunde O; Charyeva Z; Cannon M; Sambisa W; Orobaton N; Kabo IA; Shoretire K; Danladi SE; Lawal N; Sadauki H
BMC Pregnancy Childbirth; 2015 Jun; 15():130. PubMed ID: 26037906
[TBL] [Abstract][Full Text] [Related]
16. Eclampsia in Enugu, eastern Nigeria.
Ozumbia BC; Ibe AI
Acta Obstet Gynecol Scand; 1993 Apr; 72(3):189-92. PubMed ID: 8385854
[TBL] [Abstract][Full Text] [Related]
17. Situational analysis of facilitators and barriers to availability and utilization of magnesium sulfate for eclampsia and severe preeclampsia in the public health system in Brazil.
Lotufo FA; Parpinelli MA; Osis MJ; Surita FG; Costa ML; Cecatti JG
BMC Pregnancy Childbirth; 2016 Aug; 16(1):254. PubMed ID: 27577571
[TBL] [Abstract][Full Text] [Related]
18. Magnesium sulfate as an anticonvulsant in eclampsia.
Raman NV; Rao CA
Int J Gynaecol Obstet; 1995 Jun; 49(3):289-98. PubMed ID: 9764868
[TBL] [Abstract][Full Text] [Related]
19. Reducing eclampsia-related deaths--a call to action.
Langer A; Villar J; Tell K; Kim T; Kennedy S
Lancet; 2008 Mar; 371(9614):705-6. PubMed ID: 18313488
[No Abstract] [Full Text] [Related]
20. Eclampsia : before and after magnesium sulphate.
Chaudhary P
JNMA J Nepal Med Assoc; 2005; 44(160):124-8. PubMed ID: 16751814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
